Intermountain Precision Genomics Announces Advancements in Personalized Cancer Care with Expanded TheraMap Test
Intermountain Precision Genomics continues to expand cancer testing through advancements to TheraMap, a test for advanced-stage cancer patients. The new TheraMap test expands the ability to examine a tumor's DNA to provide individualized treatment options.
View full press release